30 Day Trial


Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.


  • 3:00 p.m. Bone Therapeutics’ first efficacy study of the JTA-004 viscosupplement to treat knee OA showed that a single injection delivered higher pain reduction vs. a reference product.
  • OrthAlign announced the first procedures featuring its KneeAlign® CFS™ rotation and soft tissue balancing system, an accessory that can be used during KneeAlign-assisted total knee arthroplasties.
  • 3:15 p.m. DePuy Synthes entered into an exclusive U.S. co-promotion agreement with Ortho Development for the KASM® Knee Articulating Spacer Mold.
Read More

Articles of Interest All Articles

Healthpoint Capital Closes $100MM for New Fund

HealthpointCapital, a private equity firm focused on musculoskeletal healthcare, announced it closed U.S. $100MM for its fourth fund. The target for Musculoskeletal Fund IV is $500MM.